The new generation of weight-loss drugs

These drugs imitate a hormone known as GLP-1 (it stands for glugacon-like peptide-1), which is secreted by the intestines. It stimulates insulin production and creates a feeling of fullness, suppressing the appetite.

Illustration of an inactivated glucagon-like peptide-1 (GLP-1) receptor (blue) surrounded by semaglutide agonists (red). (AFP)